TMDX
Price:
$78.79
Market Cap:
$2.72B
TransMedics Group, Inc. operates as a commercial-stage medical technology enterprise, committed to transforming the landscape of organ transplant therapy for patients worldwide grappling with end-stage organ failure. At the core of their offerings is the Organ Care System (OCS), an innovative, portable solution engineered to perfuse, optimize, and continuously monitor donor organs. This system leverages exclusive, tailored technology to meticulously recreate near-physiological conditions for these vital organs while they remain outside the human body. The OCS suite encompasses specialized modules: OCS LUNG, which facilitates the preservation of standard criteria donor lungs for double-lung t...[Read more]
Industry
Medical - Devices
IPO Date
2019-05-02
Stock Exchange
NASDAQ
Ticker
TMDX
According to TransMedics Group, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is 18.03. This represents a change of -63.99% compared to the average of 50.06 of the last 4 quarters.
The mean historical PE Ratio of TransMedics Group, Inc. over the last ten years is -15.71. The current 18.03 PE Ratio has changed -11580.21% with respect to the historical average. Over the past ten years (40 quarters), TMDX's PE Ratio was at its highest in in the September 2024 quarter at 301.92. The PE Ratio was at its lowest in in the June 2023 quarter at -681.66.
Average
-15.71
Median
-14.50
Minimum
-102.51
Maximum
58.27
Discovering the peaks and valleys of TransMedics Group, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 319.03%
Maximum Annual PE Ratio = 58.27
Minimum Annual Increase = -156.85%
Minimum Annual PE Ratio = -102.51
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | 21.72 | -62.72% |
| 2024 | 58.27 | -156.85% |
| 2023 | -102.51 | 104.28% |
| 2022 | -50.18 | 319.03% |
| 2021 | -11.97 | -30.20% |
| 2020 | -17.16 | 112.97% |
| 2019 | -8.06 | -55.69% |
| 2018 | -18.18 | 17.07% |
| 2017 | -15.53 | 15.28% |
The current PE Ratio of TransMedics Group, Inc. (TMDX) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-7.50
5-year avg
-16.93
10-year avg
-15.71
TransMedics Group, Inc.’s PE Ratio is greater than Option Care Health, Inc. (17.05), greater than Glaukos Corporation (-39.84), greater than Akero Therapeutics, Inc. (-14.61), greater than Oscar Health, Inc. (-74.74), greater than Immunovant, Inc. (-12.71), greater than Kymera Therapeutics, Inc. (-25.26), greater than NewAmsterdam Pharma Company N.V. (-16.48), less than Indivior Pharmaceuticals Inc (19.05), greater than Hinge Health, Inc. (-10.54), greater than Bruker Corporation (-239.46),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.05 | $3.45B | |
| -39.84 | $7.68B | |
| -14.61 | $4.50B | |
| -74.74 | $7.36B | |
| -12.71 | $7.26B | |
| -25.26 | $7.44B | |
| -16.48 | $3.49B | |
| 19.05 | $4.78B | |
| -10.54 | $5.37B | |
| -239.46 | $8.71B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like TransMedics Group, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like TransMedics Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is TransMedics Group, Inc.'s PE Ratio?
How is the PE Ratio calculated for TransMedics Group, Inc. (TMDX)?
What is the highest PE Ratio for TransMedics Group, Inc. (TMDX)?
What is the 3-year average PE Ratio for TransMedics Group, Inc. (TMDX)?
What is the 5-year average PE Ratio for TransMedics Group, Inc. (TMDX)?
How does the current PE Ratio for TransMedics Group, Inc. (TMDX) compare to its historical average?